V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220021 | 20083815 | 1.73 | 100.5 | Palliative (P) | 2019-10-14 | 2019-10-22 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100959567 |
| 20220023 | 20083816 | 1.69 | 83.8 | Curative (C) | 2017-04-30 | 2017-04-30 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 100484855 |
| 20220027 | 20083817 | 1.6 | null | Palliative (P) | 2016-05-25 | 2016-06-16 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101100293 |
| 20220033 | 20083818 | 1.63 | 71.6 | Palliative (P) | 2015-08-25 | 2015-08-26 | Enzalutamide | 02 | N | CETUXIMAB | 100254437 |
| 20220037 | 20083819 | 1.58 | 88 | null | 2019-03-23 | 2019-03-24 | Enzalutamide | 02 | Y | OCTREOTIDE | 101451647 |
| 20220041 | 20083820 | 1.5 | 59.8 | Neo-adjuvant (N) | 2015-07-24 | 2015-07-30 | Enzalutamide | 2 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100620648 |
| 20220042 | 20083821 | 1.6 | 54.7 | Palliative (P) | 2020-10-19 | 2020-10-27 | Enzalutamide | N | N | CARBOPLATIN | 100806014 |
| 20220049 | 20083822 | 1.51 | 102.5 | Curative (C) | 2019-08-14 | 2019-08-19 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100911492 |
| 20220051 | 20083823 | 1.67 | 55.25 | Neo-adjuvant (N) | 2020-04-01 | 2020-04-01 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100034482 |
| 20220058 | 20083824 | 0 | 0 | Palliative (P) | 2016-11-29 | 2016-11-29 | Enzalutamide | 02 | Y | CARBOPLATIN + GEMCITABINE | 100620217 |
| 20220059 | 20083825 | 1.71 | 51.4 | Adjuvant (A) | 2016-01-21 | 2016-02-17 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100543008 |
| 20220061 | 20083826 | 1.81 | 65.6 | Palliative (P) | 2019-01-06 | 2019-01-12 | Enzalutamide | 02 | N | CETUXIMAB | 101638405 |
| 20220064 | 20083827 | 1.65 | 106.4 | null | 2014-12-04 | 2014-12-04 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | null | ENZALUTAMIDE | 101560080 |
| 20220065 | 20083828 | 0 | 70 | Curative (C) | 2018-10-20 | 2018-11-03 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 100503704 |
| 20220067 | 20083829 | 1.62 | 73.1 | Neo-adjuvant (N) | 2016-11-21 | 2016-12-21 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100326450 |
| 20220070 | 20083830 | 1.68 | 84 | Curative (C) | 2018-03-15 | 2018-03-15 | Enzalutamide | N | N | ECF | 101607846 |
| 20220072 | 20083831 | 0 | 0 | Palliative (P) | 2019-10-16 | 2019-10-16 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101168365 |
| 20220075 | 20083832 | 1.75 | null | 03 | 2018-04-25 | 2018-04-29 | Enzalutamide | 2 | N | TRASTUZUMAB | 101376103 |
| 20220078 | 20083833 | null | 96 | Adjuvant (A) | 2016-03-17 | 2016-03-18 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100310600 |
| 20220083 | 20083834 | 1.7 | 84 | Palliative (P) | 2017-11-18 | 2017-11-19 | Enzalutamide | 99 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100464300 |
| 20220084 | 20083835 | 0 | 60 | null | 2018-09-02 | 2018-09-24 | Enzalutamide | 02 | null | OCTREOTIDE | 100169416 |
| 20220085 | 20083836 | 1.69 | 72 | Curative (C) | 2015-12-10 | 2015-12-10 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100155608 |
| 20220086 | 20083837 | 1.6 | 54.3 | Curative (C) | null | 2019-03-30 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101380922 |
| 20220087 | 20083838 | 0 | 0 | Neo-adjuvant (N) | 2017-06-18 | 2017-06-23 | Enzalutamide | 02 | Y | ECF | 100619517 |
| 20220090 | 20083839 | 1.68 | 77 | Neo-adjuvant (N) | null | 2016-03-11 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101195726 |
| 20220091 | 20083840 | 1.67 | 122 | Curative (C) | null | 2021-07-08 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 100566479 |
| 20220094 | 20083841 | 1.7 | 82 | Palliative (P) | 2019-01-26 | 2019-02-09 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100584869 |
| 20220096 | 20083842 | 1.7 | 79.2 | Palliative (P) | 2019-04-29 | 2019-04-29 | SCALOP-2 Trial | 01 | N | SCALOP-2 TRIAL | 100136883 |
| 20220097 | 20083843 | 0 | 64.1 | Palliative (P) | 2018-08-12 | 2018-08-14 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101778607 |
| 20220098 | 20083844 | 1.64 | 57.2 | Palliative (P) | 2016-03-29 | 2016-04-28 | Enzalutamide | N | N | CISPLATIN | 101329988 |
| 20220104 | 20083845 | 1.81 | 82.9 | Palliative (P) | 2016-05-25 | 2016-05-25 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101774436 |
| 20220106 | 20083846 | 1.57 | 71 | Curative (C) | 2016-09-22 | 2016-09-24 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101686722 |
| 20220115 | 20083847 | 1.5 | 80.65 | null | 2019-09-26 | 2019-09-26 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 100125841 |
| 20220122 | 20083848 | null | 79 | Palliative (P) | null | 2017-02-10 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100870032 |
| 20220123 | 20083849 | 1.72 | 45.6 | Neo-adjuvant (N) | 2017-01-28 | 2017-01-28 | Enzalutamide | 02 | N | CARBOPLATIN | 100763126 |
| 20220126 | 20083850 | 1.67 | 56 | null | 2016-05-15 | 2016-05-15 | Enzalutamide | N | null | CETUXIMAB + OXALIPLATIN + MDG | 100147501 |
| 20220130 | 20083851 | 1.67 | 106.2 | Curative (C) | 2020-08-03 | 2020-08-15 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | SCALOP-2 TRIAL | 100069666 |
| 20220131 | 20083852 | 1.65 | 54.5 | Palliative (P) | 2017-12-31 | 2018-01-20 | Cetuximab 14 day | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100457741 |
| 20220133 | 20083853 | 1.84 | 84 | null | 2018-08-04 | 2018-08-19 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101792014 |
| 20220137 | 20083854 | 1.79 | 72.1 | Palliative (P) | 2018-10-09 | 2018-10-22 | Enzalutamide | null | N | CAPECITABINE + TEMOZOLOMIDE | 100766657 |
| 20220142 | 20083855 | 1.77 | 82.9 | Curative (C) | null | 2018-11-22 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 101153525 |
| 20220143 | 20083856 | 1.59 | 104.2 | Curative (C) | 2018-04-14 | 2018-04-28 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100698755 |
| 20220144 | 20083857 | 0 | 103 | null | 2017-09-08 | 2018-01-05 | LU-177 | 02 | null | LUTETIUM-177 | 100017425 |
| 20220151 | 20083858 | 1.77 | 84.5 | Curative (C) | null | 2016-05-31 | Enzalutamide | 2 | null | CISPLATIN | 101637444 |
| 20220152 | 20083859 | 0 | 0 | Palliative (P) | 2019-02-20 | 2019-02-20 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101373786 |
| 20220157 | 20083860 | 1.67 | 56 | null | 2017-11-16 | 2017-11-30 | Enzalutamide | 2 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100689264 |
| 20220159 | 20083861 | 1.77 | 65 | Palliative (P) | 2019-08-27 | 2019-09-06 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100338842 |
| 20220163 | 20083862 | 1.54 | 74.6 | Palliative (P) | 2017-11-22 | 2017-11-22 | Enzalutamide | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101768239 |
| 20220167 | 20083863 | 1.68 | 58.4 | null | 2021-12-20 | 2021-12-20 | Enzalutamide | 02 | null | ECF | 101793898 |
| 20220173 | 20083864 | 1.72 | 63.5 | 02 | 2017-01-03 | 2017-01-14 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100927755 |